Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Overexpression of the fatty acid synthase (FASN) gene has been implicated in prostate carcinogenesis. We sought to directly assess the oncogenic potential of FASN. METHODS: We used immortalized human prostate epithelial cells (iPrECs), androgen receptor-overexpressing iPrECs (AR-iPrEC), and human prostate adenocarcinoma LNCaP cells that stably overexpressed FASN for cell proliferation assays, soft agar assays, and tests of tumor formation in immunodeficient mice. Transgenic mice expressing FASN in the prostate were generated to assess the effects of FASN on prostate histology. Apoptosis was evaluated by Hoechst 33342 staining and by fluorescence-activated cell sorting in iPrEC-FASN cells treated with stimulators of the intrinsic and extrinsic pathways of apoptosis (ie, camptothecin and anti-Fas antibody, respectively) or with a small interfering RNA (siRNA) targeting FASN. FASN expression was compared with the apoptotic index assessed by the terminal deoxynucleotidyltransferase-mediated UTP end-labeling method in 745 human prostate cancer samples by using the least squares means procedure. All statistical tests were two-sided. RESULTS: Forced expression of FASN in iPrECs, AR-iPrECs, and LNCaP cells increased cell proliferation and soft agar growth. iPrECs that expressed both FASN and androgen receptor (AR) formed invasive adenocarcinomas in immunodeficient mice (12 of 14 mice injected formed tumors vs 0 of 14 mice injected with AR-iPrEC expressing empty vector (P < .001, Fisher exact test); however, iPrECs that expressed only FASN did not. Transgenic expression of FASN in mice resulted in prostate intraepithelial neoplasia, the incidence of which increased from 10% in 8- to 16-week-old mice to 44% in mice aged 7 months or more (P = .0028, Fisher exact test), but not in invasive tumors. In LNCaP cells, siRNA-mediated silencing of FASN resulted in apoptosis. FASN overexpression protected iPrECs from apoptosis induced by camptothecin but did not protect iPrECs from Fas receptor-induced apoptosis. In human prostate cancer specimens, FASN expression was inversely associated with the apoptotic rate (mean percentage of apoptotic cells, lowest vs highest quartile of FASN expression: 2.76 vs 1.34, difference = 1.41, 95% confidence interval = 0.45 to 2.39, Ptrend = .0046). CONCLUSIONS: These observations suggest that FASN can act as a prostate cancer oncogene in the presence of AR and that FASN exerts its oncogenic effect by inhibiting the intrinsic pathway of apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Yonehara, S., Ishii, A., & Yonehara, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.5.1747 · Cited by 1,400
Prospective study of alcohol consumption and risk of coronary disease in men.
Rimm, E. B., Giovannucci, E. L., Willett, W. C., Colditz, G. A., Ascherio, A., Rosner, B., & Stampfer, M. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)90542-w · Cited by 1,239
Self-citation20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Albertsen, P. C. (2005) · JAMA · doi:10.1001/jama.293.17.2095 · Cited by 1,187
The apoptosome: Signalling platform of cell death
Riedl, S. J., & Salvesen, G. S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2153 · Cited by 1,097
ATP citrate lyase inhibition can suppress tumor cell growth
Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.008 · Cited by 1,086
Pagano, M., Gauvreau, K., & Mattie, H. (2022) · Chapman & Hall/CRC eBooks · doi:10.1201/9780429340512 · Cited by 926
Sesso, H. D. (2008) · JAMA · doi:10.1001/jama.2008.600 · Cited by 913
Multiple newly identified loci associated with prostate cancer susceptibility
Collaborators, T. U. G. P. C. S., Eeles, R. A., British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. S., Kote-Jarai, Z., Giles, G. G., Olama, A. A. A., Guy, M., Jugurnauth, S. K., Mulholland, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.90 · Cited by 844
Fatty acid synthesis: a potential selective target for antineoplastic therapy
Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D., & Pasternack, G. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6379 · Cited by 705
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Kridel, S. J., Axelrod, F., Rozenkrantz, N., & Smith, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3645 · Cited by 607
Synthesis and antitumor activity of an inhibitor of fatty acid synthase
Kuhajda, F. P., Pizer, E. S., Li, J. N., Mani, N. S., Frehywot, G. L., & Townsend, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3450 · Cited by 567
The Crystal Structure of a Mammalian Fatty Acid Synthase
Maier, T., Leibundgut, M., & Ban, N. (2008) · Science · doi:10.1126/science.1161269 · Cited by 505
Ziegel, E. R., Pagano, M., & Gauvreau, K. (1994) · Technometrics · doi:10.1080/00401706.1994.10485875 · Cited by 445
Ma, J., Li, H., Giovannucci, E., Mucci, L., Qiu, W., Nguyen, P. L., Gaziano, J. M., Pollak, M., & Stampfer, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70235-3 · Cited by 421
Self-citationRole of Diet in Prostate Cancer Development and Progression
Chan, J. M., Gann, P. H., & Giovannucci, E. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1492 · Cited by 413
Body Size and Prostate Cancer: A 20-Year Follow-up Study Among 135006 Swedish Construction Workers
Andersson, S.-O., Wolk, A., Bergstrom, R., Adami, H.-O., Engholm, G., Englund, A., & Nyren, O. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.5.385 · Cited by 406
Medes, G., Thomas, A. J., & Weinhouse, S. (1953) · PubMed · Cited by 405
Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y.-Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2489 · Cited by 392
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
Graner, E., Tang, D., Rossi, S., Baron, A., Migita, T., Weinstein, L. J., Lechpammer, M., Huesken, D., Zimmermann, J., Signoretti, S., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00055-8 · Cited by 367
Self-citationRodriguez, C., Freedland, S. J., Deka, A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Thun, M. J., & Calle, E. E. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0754 · Cited by 354
Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
Gong, Z., Neuhouser, M. L., Goodman, P. J., Albanes, D., Chi, C., Hsing, A. W., Lippman, S. M., Platz, E. A., Pollak, M. N., Thompson, I. M., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0477 · Cited by 352
Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
Rossi, S., Graner, E., Febbo, P. G., Weinstein, L. J., Bhattacharya, N., Ónody, T., Bubley, G. J., Balk, S. P., & Loda, M. F. (2003) · PubMed · Cited by 339
Self-citationWright, M. E., Chang, S., Schatzkin, A., Albanes, D., Kipnis, V., Mouw, T., Hurwitz, P., Hollenbeck, A., & Leitzmann, M. F. (2007) · Cancer · doi:10.1002/cncr.22443 · Cited by 336
Beckers, A., Organe, S., Timmermans, L., Scheys, K., Peeters, A., Brusselmans, K., Verhoeven, G., & Swinnen, J. V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0389 · Cited by 314
Alo, P. L., Visca, P., Marci, A., Mangoni, A., Botti, C., & Di Tondo, U. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960201)77:3<474::aid-cncr8>3.0.co;2-k · Cited by 313
Fatty acid synthase: A metabolic oncogene in prostate cancer?
Baron, A., Migita, T., Tang, D., & Loda, M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10708 · Cited by 292
Self-citationIncreased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival
Gansler, T. S., Hardman, W., Hunt, D. A., Schaffel, S., & Hennigar, R. A. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90177-5 · Cited by 287
Brusselmans, K., De Schrijver, E., Verhoeven, G., & Swinnen, J. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0571 · Cited by 277
Schrijver, E. D., Brusselmans, K., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2003) · PubMed · Cited by 269
Swinnen, J. V., Van Veldhoven, P. P., Timmermans, L., De Schrijver, E., Brusselmans, K., Vanderhoydonc, F., Van de Sande, T., Heemers, H., Heyns, W., & Verhoeven, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00265-1 · Cited by 259
Pizer, E. S., Chrest, F. J., DiGiuseppe, J. A., & Han, W. F. (1998) · PubMed · Cited by 250
Cerhan, J. R., Torner, J. C., Lynch, C. F., Rubenstein, L. M., Lemke, J. H., Cohen, M. B., Lubaroff, D. M., & Wallace, R. B. (1997) · Cancer Causes & Control · doi:10.1023/a:1018428531619 · Cited by 238
Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men
Engeland, A., Tretli, S., & Bjørge, T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601206 · Cited by 217
Liu, H., Liu, Y., & Zhang, J.-T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0445 · Cited by 216
Shurbaji, M. S., Kalbfleisch, J. H., & Thurmond, T. S. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90218-x · Cited by 208
METABOLISM OF NEOPLASTIC TISSUE
Jedeikin, L. A., & Weinhouse, S. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71063-6 · Cited by 207
Vazquez‐Martin, A., Colomer, R., Brunet, J., Lupu, R., & Menendez, J. A. (2008) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00498.x · Cited by 199
A randomized trial of aspirin and β-carotene among U.S. physicians
Hennekens, C. H., & Eberlein, K. (1985) · Preventive Medicine · doi:10.1016/0091-7435(85)90031-3 · Cited by 186
Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells
Berger, R., Febbo, P. G., Majumder, P. K., Zhao, J. J., Mukherjee, S., Signoretti, S., Campbell, K. T., Sellers, W. R., Roberts, T. M., Loda, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2938 · Cited by 177
Self-citationCarvalho, M. A., Zecchin, K. G., Seguin, F., Bastos, D. C., Agostini, M., Rangel, A. L. C. A., Veiga, S. S., Raposo, H. F., Oliveira, H. C. F., Loda, M., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23835 · Cited by 171
Self-citationLi, J. N., Gorospe, M., Chrest, F. J., Kumaravel, T. S., Evans, M. K., Han, W. F., & Pizer, E. S. (2001) · PubMed · Cited by 166
Kusakabe, T., Maeda, M., Hoshi, N., Sugino, T., Watanabe, K., Fukuda, T., & Suzuki, T. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800505 · Cited by 158
Vāvere, A. L., Kridel, S. J., Wheeler, F. B., & Lewis, J. S. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046672 · Cited by 154
The Isopeptidase USP2a Protects Human Prostate Cancer from Apoptosis
Priolo, C., Tang, D., Brahamandan, M., Benassi, B., Sicinska, E., Ogino, S., Farsetti, A., Porrello, A., Finn, S., Zimmermann, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1374 · Cited by 149
Self-citationFatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma☆
SHAH, U., Dhir, R., Gollin, S. M., Chandran, U. R., Lewis, D. A., Acquafondata, M. B., & Pflug, B. R. (2006) · Human Pathology · doi:10.1016/j.humpath.2005.11.022 · Cited by 140
Van de Sande, T., Roskams, T., Lerut, E., Joniau, S., Van Poppel, H., Verhoeven, G., & Swinnen, J. V. (2005) · The Journal of Pathology · doi:10.1002/path.1760 · Cited by 136
Pizer, E. S., Wood, F. D., Pasternack, G. R., & Kuhajda, F. P. (1996) · PubMed · Cited by 132
Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma.
Visca, P., Sebastiani, V., Botti, C., Diodoro, M. G., Lasagni, R. P., Romagnoli, F., Brenna, A., de Joannon, B. C., Donnorso, R. P., Lombardi, G., et al. (2004) · PubMed · Cited by 128
Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas.
Tajino, T., Kikuchi, S., & Toshimitsu, S. (2003) · PubMed · Cited by 116
Obesity, adipokines, and prostate cancer (Review)
Baillargeon, J., & Rose, D. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.3.737 · Cited by 110
Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis.
Furuya, Y., Akimoto, S., Yasuda, K., & Ito, H. (1997) · PubMed · Cited by 64
Gastrointestinal stromal tumours overexpress fatty acid synthase
Rossi, S., Ou, W., Tang, D., Bhattacharya, N., Tos, A. P. D., Fletcher, J. A., & Loda, M. F. (2006) · The Journal of Pathology · doi:10.1002/path.1983 · Cited by 59
Self-citationMolecular genetics of human prostate cancer
Rubin, M. A., & Marzo, A. M. D. (2004) · Modern Pathology · doi:10.1038/modpathol.3800051 · Cited by 56
Vázquez, M. J., Leavens, W. J., Liu, R., Rodríguez, B., Read, M., Richards, S., Winegar, D. A., & Domı́nguez, J. M. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06314.x · Cited by 47
Synthesis of Novel β-Lactone Inhibitors of Fatty Acid Synthase
Richardson, R. D., Ma, G., Oyola, Y., Zancanella, M., Knowles, L., Cieplak, P., Romo, D., & Smith, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800321h · Cited by 46
Uzzo, R. G., Haas, N. B., Crispen, P. L., & Kolenko, V. M. (2008) · Cancer · doi:10.1002/cncr.23318 · Cited by 26
Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride
Schmidt, L. J., Ballman, K. V., & Tindall, D. J. (2007) · The Prostate · doi:10.1002/pros.20602 · Cited by 26
Novel Targeted Pro-Apoptotic Agents for the Treatment of Prostate Cancer
Huang, X., Zhang, X., Farahvash, B., & Olumi, A. F. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.06.039 · Cited by 13
Cited by
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Jeon, S.-M., Chandel, N. S., & Hay, N. (2012) · Nature · doi:10.1038/nature11066 · Cited by 1,132
Yue, S., Li, J., Lee, S.-Y., Lee, H. J., Shao, T., Song, B., Cheng, L., Masterson, T. A., Liu, X., Ratliff, T. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.019 · Cited by 929
Schug, Z. T., Peck, B., Jones, D. T., Zhang, Q., Grosskurth, S., Alam, I. S., Goodwin, L. M., Smethurst, E., Mason, S., Blyth, K., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.002 · Cited by 820
“It has even been suggested that FASN itself can be sufficient to drive the transformation of prostate cells and may be a good target for antineoplastic therapy (Migita et al., 2009).”
BackgroundRysman, E., Brusselmans, K., Scheys, K., Timmermans, L., Derua, R., Munck, S., Van Veldhoven, P. P., Waltregny, D., Daniëls, V. W., Machiels, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3871 · Cited by 721
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Massie, C. E., Lynch, A., Ramos‐Montoya, A., Boren, J., Stark, R., Fazli, L., Warren, A., Scott, H., Madhu, B., Sharma, N., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.158 · Cited by 624
Metadata
- Authors
- Migita, T., Ruiz, S., Fornari, A., Fiorentino, M., Priolo, C., Zadra, G., Inazuka, F., Grisanzio, C., Palescandolo, E., Shin, E., Fiore, C., Xie, W., Kung, A. L., Febbo, P. G., Subramanian, A., Mucci, L., Ma, J., Signoretti, S., Stampfer, M., Hahn, W. C., Finn, S., & Loda, M.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04-01
- Volume
- 101
- Issue
- 7
- Pages
- 519-532
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2104424545
- Cited by
- 387
- References
- 62
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.